Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.

Tähtelä, Riitta

Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide. [electronic resource] - Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Sep 2005 - 1109-16 p. digital

Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial

0937-941X

10.1007/s00198-004-1819-7 doi


Acid Phosphatase--blood
Biomarkers--metabolism
Bone Density--drug effects
Bone Density Conservation Agents--therapeutic use
Bone Diseases, Metabolic--drug therapy
Clodronic Acid--therapeutic use
Collagen--urine
Collagen Type I
Double-Blind Method
Drug Monitoring--methods
Female
Femur--physiopathology
Femur Neck--physiopathology
Follow-Up Studies
Humans
Isoenzymes--blood
Lumbar Vertebrae--physiopathology
Middle Aged
Peptide Fragments--blood
Peptides--urine
Postmenopause--metabolism
Procollagen--blood
Tartrate-Resistant Acid Phosphatase
Treatment Outcome